​

Funding Round

Series E - Nalu Medical

Series E - Nalu Medical

Investment Firm

Overview

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Announced Date

Jan 03, 2024

Closed on Date

Mar 05, 2024

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

Novo Holdings

Novo Holdings

Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorMVM Life Science Partners
Participant InvestorNovo Holdings
Participant InvestorGilde Healthcare
Participant InvestorAdvent Life Sciences
Participant InvestorB Capital

Round Details and Background

Nalu Medical raised $85000000 on 2024-01-03 in Series E

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 17, 2022
Venture Round - Nalu Medical
8-104.0M
Jan 03, 2024
Series E - Nalu Medical
10-85.0M
Jul 10, 2015
Venture Round - Nalu Medical
2-11.9M

Recent Activity

There is no recent news or activity for this profile.